Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph early_phase_1
1
25%
Ph not_applicable
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting250%
terminated125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

NCT06819475
recruiting

Menstrual Blood Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study

NCT06214260
completed

Autoimmunity in the Pathogenesis of AF

NCT03498729
terminatedearly_phase_1

Pneumococcal Conjugate Vaccine in Aging Renal Transplant

NCT03802994

Clinical Trials (4)

Showing 4 of 4 trials
NCT06819475Not Applicable

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Recruiting
NCT06214260

Menstrual Blood Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study

Recruiting
NCT03498729

Autoimmunity in the Pathogenesis of AF

Completed
NCT03802994Early Phase 1

Pneumococcal Conjugate Vaccine in Aging Renal Transplant

Terminated

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4